AACR 2016 Annual Meeting
BERG will be attending the 2016 AACR annual meeting, April 16th to the 20th in New Orleans. We will be presenting five scientific posters showing new promising preclinical pancreatic cancer data, including new biomarkers for detection and improved treatment outcomes via the combination of BPM 31510 with gemcitabine. Additionally new data demonstrates molecular drivers of endothelial cell (EC) angiogenic response to hypoxia, and its effects. The research was guided by BERG’s Interrogative Biology ® Platform.